Genshu K. Wang
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Metabolic Reprogramming-Targeted Therapeutic Strategies in Primary Liver Cancer: A Bibliometric and Visualized Analysis.
Journal: Journal of hepatocellular carcinoma
Published: May 27, 2026
Di-2-ethylhexyl Phthalate Reprograms Epithelial-Mesenchymal Transition and Lenvatinib Responsiveness in Hepatoma Cells via SPAG4-Dependent MAPK/ERK Signaling.
Journal: Chemical research in toxicology
Published: May 13, 2026
Multifaceted mechanisms by which environmental endocrine-disrupting chemicals promote cancer progression: crosstalk among carcinogenesis, immunity, and metabolic reprogramming: narrative mini-review.
Journal: Frontiers in molecular biosciences
Published: March 25, 2026
Natural glycosides from Cistanche deserticola alleviate hepatic ischemia-reperfusion injury via a cAMP-mediated signaling pathway.
Journal: Journal of ethnopharmacology
Published: September 28, 2025
Impact of Underlying Liver Disease on the Risk and Prognostic Factors of Breast Cancer Liver Metastases: A Retrospective Multicenter Cohort Study.
Journal: Cancer medicine
Published: September 08, 2025
Nutritional Risk Predicts Hepatic Regeneration After Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy in HBV-related HCC.
Journal: Archives of medical research
Published: June 30, 2025
A modified technique for purely laparoscopic liver transplantation in a porcine model.
Journal: Chinese medical journal
Published: May 02, 2025
N6-methyladenosine-mediated up-regulation of ARRB2 regulates intrahepatic cholangiocarcinoma malignant progression and pemigatinib resistance through MAPK and Hippo signaling pathways.
Journal: Cell death & disease
Published: April 30, 2025
Regulation of cisplatin resistance in lung cancer by epigenetic mechanisms.
Journal: Clinical epigenetics
Published: March 21, 2025
Proinflammatory macrophages release CXCL5 to regulate T cell function and limit effects of αPD-1 in steatosis-driven liver cancer.
Journal: JHEP reports : innovation in hepatology
Published: May 14, 2024
Tumour burden score combined with albumin-to-alkaline phosphatase ratio predicts prognosis in patients with intrahepatic cholangiocarcinoma.
Journal: Journal of cellular and molecular medicine
Published: May 03, 2024
Last Updated: 09/26/2026